Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Michael, Benenson"'
Autor:
Punnee Pitisuttithum, Supachai Rerks-Ngarm, Valai Bussaratid, Jittima Dhitavat, Wirach Maekanantawat, Swangjai Pungpak, Pravan Suntharasamai, Sirivan Vanijanonta, Sorachai Nitayapan, Jaranit Kaewkungwal, Michael Benenson, Patricia Morgan, Robert J O'Connell, Jeffrey Berenberg, Sanjay Gurunathan, Donald P Francis, Robert Paris, Joseph Chiu, Donald Stablein, Nelson L Michael, Jean-Louis Excler, Merlin L Robb, Jerome H Kim
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e27837 (2011)
A prime-boost vaccination regimen with ALVAC-HIV (vCP1521) administered intramuscularly at 0, 4, 12, and 24 weeks and gp120 AIDSVAX B/E at 12 and 24 weeks demonstrated modest efficacy of 31.2% for prevention of HIV acquisition in HIV-uninfected adult
Externí odkaz:
https://doaj.org/article/932fc5691218438b9c3e98883140fb14
Autor:
John G. McNeil, Sodsai Tovanabutra, Deborah L. Birx, Narongrid Sirisopana, Veerachai Watanaveeradej, Chris Beyrer, Kwanjai Viputtikul, Vinai Suriyanon, Mark de Souza, Jean K. Carr, Merlin L. Robb, Myat Htoo Razak, Jaroon Jittiwutikarn, Michael Benenson, Somchai Sriplienchan, Arthur Brown, Philip O. Renzullo, Francine E. McCutchan, David D. Celentano, Sorachai Nitayaphan
Publikováno v:
AIDS Research and Human Retroviruses. 19:561-567
HIV-1 subtype B and CRF01_AE have been in circulation in Thailand and Southeast Asia for more than a decade. Initially separated by risk group, the two strains are increasingly intermixed, and two recombinant strains of essentially reciprocal structu
Autor:
Mark S. deSouza, Narongrid Sirisopana, Francine E. McCutchan, Deborah L. Birx, Veerachai Watanaveeradej, Eric Sanders-Buell, Jean K. Carr, Michael Benenson, Sorachai Nitayaphan, Penprapa Chanbancherd, Arthur E. Brown
Publikováno v:
AIDS. 17:2138-2140
The first HIV-1 recombinant between CRF01―AE and subtype C, NP1809, has been identified in Thailand. The nearly full genome was polymerase chain reaction amplified, sequenced and phylogenetically analysed. NP1809 was a complex recombinant, with at
Autor:
Michael Benenson, Sanjay Gurunathan, Don Stablein, Supachai Rerks-Ngarm, Punnee Pitisuttithum, Prasert Thongcharoen, Jerome H. Kim, Sorachai Nitayaphan, Elizabeth Adams, Merlin L. Robb, Chirasak Khamboonruang, Jim Tartaglia, Peter B. Gilbert, Jaranit Kaewkungwal, Patricia Morgan, Donald P. Francis, Joseph Chiu, Prayura Kunasol, Nelson L. Michael, Robert Paris
Publikováno v:
The Lancet. Infectious diseases. 12(7)
Summary Background The Thai phase 3 HIV vaccine trial RV 144 showed modest efficacy of a vaccine against HIV acquisition. Baseline variables of age, sex, marital status, and risk did not modify vaccine efficacy. We did a post-hoc analysis of the tria
Autor:
Punnee, Pitisuttithum, Supachai, Rerks-Ngarm, Joseph, Chiu, Jerome, Kim, Michael, Benenson, Stephen J, Kent, Hiko, Tamashiro, Amapola, Manrique, Alan, Bernstein, Rajat, Goyal, Rossana A, Ditangco, David A, Cooper, Saladin, Osmanov, Bonnie, Mathieson, Eric, Sandstrom, Jose, Esparza, Rodney, Hoff, Yiming, Shao
Publikováno v:
The Southeast Asian journal of tropical medicine and public health. 42(5)
HIV/AIDS is a major public health problem worldwide, especially in developing countries. The development of a safe and effective HIV vaccine is central to stopping the epidemic and would be a great public health tool. The AIDS Vaccine for Asia Networ
Autor:
Supachai, Rerks-Ngarm, Punnee, Pitisuttithum, Sorachai, Nitayaphan, Jaranit, Kaewkungwal, Joseph, Chiu, Robert, Paris, Nakorn, Premsri, Chawetsan, Namwat, Mark, de Souza, Elizabeth, Adams, Michael, Benenson, Sanjay, Gurunathan, Jim, Tartaglia, John G, McNeil, Donald P, Francis, Donald, Stablein, Deborah L, Birx, Supamit, Chunsuttiwat, Chirasak, Khamboonruang, Prasert, Thongcharoen, Merlin L, Robb, Nelson L, Michael, Prayura, Kunasol, Jerome H, Kim, J, Berenberg
Publikováno v:
The New England journal of medicine. 361(23)
The development of a safe and effective vaccine against the human immunodeficiency virus type 1 (HIV-1) is critical to pandemic control.In a community-based, randomized, multicenter, double-blind, placebo-controlled efficacy trial, we evaluated four
Autor:
Sodsai Tovanabutra, Deborah L. Birx, Chalermsri Tontichaivanich, Narongrid Sirisopana, Sorachai Nitayaphan, Philip O. Renzullo, Jean K. Carr, Michael Benenson, Arthur E. Brown, Francine E. McCutchan, Veerachai Watanaveeradej, Merlin L. Robb, John G. McNeil, Mark de Souza, Ramase Amphaipit
Publikováno v:
AIDS research and human retroviruses. 22(8)
To characterize HIV-1 genotypes in candidate populations for a prime-boost phase III vaccine trial in Thailand, specimens from prevalent and incident HIV-1 infections from a family planning clinic population in Rayong Province and a community cohort
Autor:
Deborah L. Birx, Sanjay Gurunathan, Valai Bussaratid, Patricia Morgan, Sorachai Nitayaphan, William L. Heyward, Michael Benenson, Tom VanCott, Raphaelle El Habib, Chitraporn Karnasuta, Chirapa Eamsila, Silvia Ratto-Kim, John J McNeil, Darawan Thapinta, Pricha Singharaj, Arthur Brown, Robin P. Garner, Mark de Souza, Punnee Pitisuttithum, Jerome H. Kim, Victoria R. Polonis
Publikováno v:
The Journal of infectious diseases. 190(4)
ALVAC-HIV (vCP1521) and AIDSVAX B/E were evaluated in a phase 1/2 trial of human immunodeficiency virus (HIV)– negative Thai adults. Of 133 volunteers enrolled 122 completed the trial. There were no serious vaccine-related adverse events nor were t
Autor:
Ramase Amphaiphis, Khin Saw Aye Myint, Narongrid Sirisopana, Chalermsri Tuntichaivanich, Michael Benenson, Robert Paris, Arthur E. Brown
Publikováno v:
AIDS (London, England). 17(9)
Objectives: To study the association between hepatitis C virus (HCV) and HIV-1 and HCV seropositivity as an indicator of HIV-1 risk behavior for HIV vaccine preparatory cohorts in Thailand. Design: Cross-sectional study of HIV-1-infected persons iden
Autor:
Robert Paris, Chirasak Khamboonruang, Nelson L. Michael, Sodsai Tovanabutra, Mark de Souza, Chawetsan Namwat, Prasert Thongcharoen, Merlin L. Robb, Nakorn Premsri, Meera Bose, Francine E. McCutchan, Sorachai Nitayaphan, Michael Benenson, Prayura Kunasol, Supachai Rerks-Ngarm, Eric Sanders-Buell, Patricia Morgan, Gustavo H. Kijak, Deborah L. Birx, Chirapa Eamsila, Jerome H. Kim
Publikováno v:
Journal of Virology. 87:13084-13084
The RV144 HIV-1 vaccine trial (Thailand, 2003 to 2009), using immunogens genetically matched to the regional epidemic, demonstrated the first evidence of efficacy for an HIV-1 vaccine. Here we studied the molecular evolution of the HIV-1 epidemic fro